FDA says Sanit Technologies (Durisan) released contaminated alcohol-free hand sanitizer, including Burkholderia cepacia, made with contaminated water.
What happened
FDA inspected the Sarasota, Florida drug manufacturing facility from March 1 to 5, 2021. Investigators found the company's quality unit approved and released alcohol-free hand sanitizer lots that failed microbial limits from at least March through December 2020, including three lots where Burkholderia cepacia, an organism that can cause infection, was found. The company's water system also produced water with microorganisms too numerous to count, and the firm kept making and shipping product anyway.
What FDA found
The quality unit approved and released hand sanitizer lots that failed microbial limits, including lots containing Burkholderia cepacia.
21 CFR 211.22The firm did not open or fully investigate out-of-specification microbial results for finished products or failures in its water system.
21 CFR 211.192The water system used to make the drugs produced water with microorganisms too numerous to count, and the firm still used it instead of rejecting it.
21 CFR 211.63The firm had no settled finished-product specification for its active ingredient, benzalkonium chloride, and kept changing it.
21 CFR 211.160(b)The firm had no stability program to show the drug keeps its quality through its expiry date.
21 CFR 211.166(a)
What FDA wants
FDA asks the company to acknowledge in writing its responsibility for all products still on the market and within expiry, reconcile all recalled and remaining product, and provide a detailed plan to dissolve the business and de-register as a drug manufacturer. The company must respond in writing within 15 working days.
Who should pay attention
- retailers and brands that sold or private-labeled Durisan hand sanitizer
- school systems and childcare programs that bought bulk sanitizer
- quality units at other OTC drug manufacturers that release batches on microbial test results alone
This is a summary. Read the original letter on fda.gov.